 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Viracta Therapeutics Inc. (VIRX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-15 Purchase | 2019-07-15 4:15 pm | SUNESIS PHARMACEUTICALS INC | SNSS | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N ELMS STEVE 10% Owner | 2,500,000 | $0.6 | $1,500,000 | 10,100,000 (Indirect) | View |
| 2020-03-31 Purchase | 2020-04-02 3:30 pm | SUNESIS PHARMACEUTICALS INC | SNSS | Quinn William P. See Remarks | 12,000 | $0.5058 | $6,070 | 127,697 (Direct) | View |
| 2020-05-29 Purchase | 2020-06-05 3:18 pm | SUNESIS PHARMACEUTICALS INC | SNSS | Gullotta Tina VP | 6,000 | $0.3315 | $1,989 | 20,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-02-28 Option Award | 2019-03-04 3:08 pm | N/A N/A | SUNESIS PHARMACEUTICALS INC | SNSS | Quinn William P. See Remarks | 63,697 | $0 | 115,697 (Direct) | View |
| 2019-03-29 Option Award | 2019-04-01 4:13 pm | N/A 2029-03-29 | SUNESIS PHARMACEUTICALS INC | SNSS | Fox Judith A. Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-03-29 Option Award | 2019-04-01 4:14 pm | N/A 2029-03-29 | SUNESIS PHARMACEUTICALS INC | SNSS | Quinn William P. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:19 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Pearce Homer L Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:21 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Wolff Henry Ward Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:21 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | STUMP DAVID C Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:23 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Ketchum Steven B Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:24 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Carchedi Steve Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:28 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | YOUNG JAMES W Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:31 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton CEO | 60,000 | $0 | 60,000 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-02 5:31 pm | N/A 2029-06-28 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton CEO | 480,000 | $0 | 480,000 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-12 4:40 pm | N/A 2029-07-31 | SUNESIS PHARMACEUTICALS INC | SNSS | Fox Judith A. See Remarks | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-09-30 Option Award | 2019-10-01 2:29 pm | N/A 2029-09-30 | SUNESIS PHARMACEUTICALS INC | SNSS | ONETTO NICOLE Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 3:25 pm | N/A 2030-03-31 | SUNESIS PHARMACEUTICALS INC | SNSS | Fox Judith A. See Remarks | 457,500 | $0 | 457,500 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 3:28 pm | N/A 2030-03-31 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton CEO | 480,000 | $0 | 480,000 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 3:30 pm | N/A 2030-03-31 | SUNESIS PHARMACEUTICALS INC | SNSS | Quinn William P. See Remarks | 360,000 | $0 | 360,000 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-05 3:18 pm | N/A 2030-05-29 | SUNESIS PHARMACEUTICALS INC | SNSS | Gullotta Tina VP | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:39 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | STUMP DAVID C Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:45 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Ketchum Steven B Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:46 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Carchedi Steve Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:52 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | YOUNG JAMES W Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:55 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Wolff Henry Ward Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:05 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | ONETTO NICOLE Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:08 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Pearce Homer L Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:15 pm | N/A 2030-06-30 | SUNESIS PHARMACEUTICALS INC | SNSS | Misfeldt Dayton Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:00 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 78,912 | $0 | 78,912 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:03 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO | 441,993 | $0 | 441,993 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:07 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:11 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:13 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:16 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:18 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Roshwalb Gur Director 10% Owner | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:21 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:23 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Huang Michael Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:25 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | ONETTO NICOLE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 8:28 pm | N/A 2031-03-26 | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 126,890 | $0 | 126,890 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:46 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 32,689 | $1.26 | 32,689 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:46 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,061 | $3.58 | 34,750 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:46 pm | N/A 2030-07-08 | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 32,689 | $0 | 98,069 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:46 pm | N/A 2031-01-08 | Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer | 2,061 | $0 | 30,956 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A N/A | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 12,000 | $0.9 | 56,760 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 5:49 pm | N/A 2029-07-30 | Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO COO | 12,000 | $0 | 98,817 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-17 6:10 pm | N/A 2031-08-16 | Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-17 6:11 pm | N/A 2031-08-16 | Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director | 80,000 | $0 | 80,000 (Direct) | View |